diaxonhit Specialty Diagnostic Solutions

WIPO WIPO 2013

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke diaxonhit Specialty Diagnostic Solutions wurde als Bildmarke am 29.03.2013 bei der Weltorganisation für geistiges Eigentum angemeldet.

Logodesign (Wiener Klassifikation)

#Briefe, die eine besondere Form des Schreibens darstellen #Farben #Überschneidende Buchstaben #Zwei vorherrschende Farben

Markendetails Letztes Update: 17. März 2022

Markenform Bildmarke
Aktenzeichen 1171782
Länder Europäische Gemeinschaft Japan Vereinigte Staaten von Amerika (USA) Schweiz China Monaco
Basismarke FR Nr. 12/3961044, 14. November 2012
Anmeldedatum 29. März 2013
Ablaufdatum 29. März 2023

Markeninhaber

63-65 boulevard Massena
F-75013 PARIS
FR

Markenvertreter

78 avenue Raymond Poincaré F-75116 PARIS FR

Waren und Dienstleistungen

05 Pharmaceutical products for the treatment of diseases; chemical and biological reagents for medical use for diagnostics, namely chemical and biological reagents for use in tests based on blood or biological biomarkers enabling the identification of patients affected by diseases or being at risk of developing a disease and for enabling the identification of patients responding to specific personalized medical treatments; biological acidic products and preparations for pharmaceutical purposes, namely pharmaceutical preparations for diagnosing diseases; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases; biopharmaceutical products for diagnosing, preventing and treating diseases; chemical preparations for medical, pharmaceutical or veterinary purposes, especially chemical preparations for diagnosing diseases and in particular infectious diseases, neurodegenerative diseases and cancers; medical and clinical diagnostic products namely beads, microspheres, nucleic acid or antigen banks, nucleic acids, antigens on beads, or on microspheres, on biochips or on other media; DNA libraries, RNA libraries and antigen libraries, namely biological materials for medical diagnosis and companion diagnosis for medical purposes; nucleic acid or antigen sequences, namely biological materials intended for medical use and medical diagnosis, namely for decoding the genes and proteins affected by diseases or revealing the transcriptomic signature of patients affected by diseases and for the detection of specific antibodies produced by patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes namely enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; chemical reagents for medical use contained in diagnostic testing kits for collecting biological samples required for the preservation of the biological material under analysis to carry out the test in appropriate conditions
10 Surgical, medical, dental and veterinary apparatus and instruments, especially apparatus and instruments, including fluorescent instruments used for identifying diseases, assessing the severity of these diseases, assessing prognoses of these diseases, measuring the progression of a disease; medical devices using beads, microspheres and fluorescent instruments, or biopsies for analyzing blood or other biological materials; apparatus for medical use for analyzing blood or other products of the human body; apparatus for for medical diagnosis, namely, kits for taking samples of blood or other products of the human body comprising medical instruments for taking blood, DNA collection for diagnosing diseases, and materials required for the preservation of any product of the human body under analysis to carry out the test under good conditions; spoons for administering medicine; containers specially adapted to the application of medicines namely small bags and pouches used for administering medicines; probes for medical use; syringes for medical use; galvanic therapeutic appliances particularly for diagnosing diseases; probes and kits for medical and clinical diagnosis
42 Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analysis; chemical research; chemistry services, namely analysis of RNA genes, antigens, tissue and samples of blood or other biological materials; biotechnological project studies for identifying people suffering from diseases and to measure the severity of these diseases, the prognoses, progression and conversion of the disease and to determine the responsiveness of patients to treatments, especially personalized medical treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analysis, namely quantification of nucleic acid content intended for medical and scientific research
44 Medical services; veterinary services; medical assistance; consultancy in the field of biotechnology and pharmacy namely to assist in the selection of people suffering from diseases for clinical trials and to offer targeted care and personalized medical solutions; hospital services; services for the pharmaceutical industry and pharmacists (preparation of prescriptions) namely immunology, infectiology, cancerology, geriatric and/or neurological services, in order to facilitate diagnoses and undertaking therapy; health care services; telemedicine services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
27. Februar 2022 2022/11 Gaz US RAW: Total Invalidation
30. Juni 2016 2017/13 Gaz CN RAW: Rule 18ter(4) all goods and services protected
09. Dezember 2014 2015/2 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
11. August 2014 2014/34 Gaz CH Ablehnung
31. Juli 2014 2014/33 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
25. Juni 2014 2014/26 Gaz EM Ablehnung
17. April 2014 2014/17 Gaz JP Ablehnung
26. März 2014 2014/14 Gaz CN Ablehnung
21. Oktober 2013 2013/43 Gaz MC Ablehnung
04. September 2013 2013/36 Gaz US Ablehnung
29. März 2013 2013/32 Gaz FR Eintragung

ID: 141171782